Cargando…

Comparison of Serum MicroRNA21 and Tumor Markers in Diagnosis of Early Non-Small Cell Lung Cancer

Objective. To compare the clinical value of serum microRNA21 (miR21) and other tumor markers in early diagnosis of non-small cell lung cancer (NSCLC). Methods. Serums carcinoembryonic antigen (CEA), cytokeratin 19 fragment (CYFRA21-1), neuron-specific enolase (NSE), and miR21 were detected in 50 NSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Mingzhong, Song, Jiangxiang, Zhou, Zhongwei, Zhu, Rong, Jin, Hao, Ji, Yuqiao, Lu, Qiang, Ju, Huixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737022/ https://www.ncbi.nlm.nih.gov/pubmed/26880855 http://dx.doi.org/10.1155/2016/3823121

Ejemplares similares

Circulating Fetuin-A and Risk of All-Cause Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2019)

Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2019)

Pilot genome-wide study of tandem 3′ UTRs in esophageal cancer using high-throughput sequencing
por: SUN, MINGZHONG, et al.
Publicado: (2014)

Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly
por: Zhou, Zhongwei, et al.
Publicado: (2020)

Circulating chemerin levels and gestational diabetes mellitus: a systematic review and meta-analysis
por: Zhou, Zhongwei, et al.
Publicado: (2018)

Mean Platelet Volume and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2018)

Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis
por: Zhou, Zhongwei, et al.
Publicado: (2017)

Serum Exosomal MicroRNA-21, MicroRNA-126, and PTEN Are Novel Biomarkers for Diagnosis of Acute Coronary Syndrome
por: Ling, Hao, et al.
Publicado: (2020)

Circulating Trimethylamine-N-Oxide and Risk of All-Cause and Cardiovascular Mortality in Patients With Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Zhou, Zhongwei, et al.
Publicado: (2022)

Low Testosterone Level and Risk of Adverse Clinical Events among Male Patients with Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Cohort Studies
por: Li, Li, et al.
Publicado: (2022)

Serum MicroRNA-21 as Marker for Necroinflammation in Hepatitis C Patients with and without Hepatocellular Carcinoma
por: Bihrer, Verena, et al.
Publicado: (2011)

Decreased Serum microRNA-21, microRNA-25, microRNA-146a, and microRNA-181a in Autoimmune Diabetes: Potential Biomarkers for Diagnosis and Possible Involvement in Pathogenesis
por: Liu, Yiwen, et al.
Publicado: (2019)

Serum microRNA-381: A Potential Marker for Early Diagnosis of Gastric Cancer
por: Li, Ye, et al.
Publicado: (2019)

Serum MicroRNA-21 as a Diagnostic Marker for Lung Carcinoma: A Systematic Review and Meta-Analysis
por: Yang, Xiaorong, et al.
Publicado: (2014)

Analysis of Serum microRNA Expression Profiles and Comparison with Small Intestinal microRNA Expression Profiles in Weaned Piglets
por: Tao, Xin, et al.
Publicado: (2016)

Expression of Serum Exosomal MicroRNA-21 in Human Hepatocellular Carcinoma
por: Wang, Hongwei, et al.
Publicado: (2014)

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China
por: Yang, Yanlong, et al.
Publicado: (2018)

Circulating Plasma Levels of MicroRNA-21 and MicroRNA-221 Are Potential Diagnostic Markers for Primary Intrahepatic Cholangiocarcinoma
por: Correa-Gallego, Camilo, et al.
Publicado: (2016)

Circulating MicroRNA-21, MicroRNA-23a, and MicroRNA-125b as Biomarkers for Diagnosis and Prognosis of Burkitt Lymphoma in Children
por: Li, Jun, et al.
Publicado: (2016)

MicroRNA-21 as an Early Marker of Nephropathy in Patients with Type 1 Diabetes
por: Fouad, Mohamed, et al.
Publicado: (2020)

Serum microRNA-21 as a Potential Biomarker for Response to Hypomethylating Agents in Myelodysplastic Syndromes
por: Kim, Yundeok, et al.
Publicado: (2014)

Serum exosomal microRNAs as predictive markers for EGFR mutations in non–small‐cell lung cancer
por: Xia, Junbo, et al.
Publicado: (2021)

Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer
por: Yang, Xia, et al.
Publicado: (2019)

An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
por: Goto, Takuma, et al.
Publicado: (2018)

MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2015)

Specific serum microRNA profile in the molecular diagnosis of Hirschsprung's disease
por: Tang, Weibing, et al.
Publicado: (2014)

MicroRNA Markers for the Diagnosis of Pancreatic and Biliary-Tract Cancers
por: Kojima, Motohiro, et al.
Publicado: (2015)

Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer
por: Bastaminejad, Saiyad, et al.
Publicado: (2017)

The MicroRNA-21 in Autoimmune Diseases
por: Wang, Shaowen, et al.
Publicado: (2016)

Engineering iodine-doped carbon dots as dual-modal probes for fluorescence and X-ray CT imaging
por: Zhang, Miaomiao, et al.
Publicado: (2015)

Role of microRNA-21 and microRNA-155 as biomarkers for bronchial asthma
por: ElKashef, Sabrin Mohamed Mohamed Abd Elhamed, et al.
Publicado: (2020)

Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection
por: Qi, Yuhua, et al.
Publicado: (2012)

Integrating serum microRNAs and electronic health records improved the diagnosis of tuberculosis
por: Gao, Shu‐Hui, et al.
Publicado: (2021)

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014)

Roles of differential expression of microRNA-21-3p and microRNA-433 in FSH regulation in rat anterior pituitary cells
por: Han, Dong-Xu, et al.
Publicado: (2017)

Serum levels of candidate microRNA diagnostic markers differ among the stages of non-small-cell lung cancer
por: Aiso, Toshiko, et al.
Publicado: (2018)

Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors
por: Hei, Yuan-Yuan, et al.
Publicado: (2022)

microRNA-21 Expression as Prognostic and Therapeutic Response Marker in Chronic Myeloid Leukaemia Patients
por: Beg Mirza, Masroor Ali, et al.
Publicado: (2019)

Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis
por: Zeng, Zongyue, et al.
Publicado: (2013)

Biobanking and microRNA – small but with great dividend
por: Ju, Jingfang
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0qlr8vaq9b1i3mu1a9pq3bh33r